DRAVPa1841 |
Sequence 3 from Patent US20170058000 B2 |
Synthetic construct |
H3N2 |
US20170058000 B2 |
DRAVPa1842 |
Sequence 4 from Patent US20170058000 B2 |
Synthetic construct |
H3N2 |
US20170058000 B2 |
DRAVPa1843 |
Sequence 5 from Patent US20170058000 B2 |
Synthetic construct |
H3N2 |
US20170058000 B2 |
DRAVPa1844 |
Sequence 6 from Patent US20170058000 B2 |
Synthetic construct |
H3N2 |
US20170058000 B2 |
DRAVPa1845 |
Sequence 7 from Patent US20170058000 B2 |
Synthetic construct |
H3N2 |
US20170058000 B2 |
DRAVPa1846 |
Sequence 8 from Patent US20170058000 B2 |
Synthetic construct |
H3N2 |
US20170058000 B2 |
DRAVPa1847 |
Sequence 9 from Patent US20170058000 B2 |
Synthetic construct |
H3N2 |
US20170058000 B2 |
DRAVPa1848 |
Sequence 10 from Patent US20170058000 B2 |
Synthetic construct |
H3N2 |
US20170058000 B2 |
DRAVPa1849 |
Sequence 11 from Patent US20170058000 B2 |
Synthetic construct |
H3N2 |
US20170058000 B2 |
DRAVPa1850 |
Sequence 13 from Patent US20170058000 B2 |
Synthetic construct |
H3N2 |
US20170058000 B2 |
DRAVPa1851 |
Sequence 1 from Patent US20160346383 B2 |
Synthetic construct |
encephalomyocarditis virus |
US20160346383 B2 |
DRAVPa1852 |
Sequence 2 from Patent US20160346383 B2 |
human ezrin protein |
encephalomyocarditis virus |
US20160346383 B2 |
DRAVPa1853 |
Sequence 3 from Patent US20160346383 B2 |
human ezrin protein |
encephalomyocarditis virus |
US20160346383 B2 |
DRAVPa1854 |
Sequence 4 from Patent US20160346383 B2 |
human ezrin protein |
encephalomyocarditis virus |
US20160346383 B2 |
DRAVPa1855 |
Sequence 1 from Patent US20240309059 A1 |
Synthetic construct |
SARS-COV-2 |
US20240309059 A1 |
DRAVPa1856 |
Sequence 4 from Patent US20240309059 A1 |
Synthetic construct |
SARS-COV-2 |
US20240309059 A1 |
DRAVPa1857 |
Sequence 6 from Patent US20240309059 A1 |
Synthetic construct |
SARS-COV-2 |
US20240309059 A1 |
DRAVPa1858 |
Sequence 53 from Patent US20240309059 A1 |
Synthetic construct |
SARS-COV-2 |
US20240309059 A1 |
DRAVPa1859 |
Sequence 54 from Patent US20240309059 A1 |
Synthetic construct |
SARS-COV-2 |
US20240309059 A1 |
DRAVPa1860 |
Sequence 52 from Patent US20240309059 A1 |
Synthetic construct |
SARS-COV-2 |
US20240309059 A1 |